52 results
8-K
NGNE
Neurogene Inc
19 Dec 23
Neurogene Doses First Patients in Phase 1/2 Trial of NGN-401 for the Treatment of Female Pediatric Patients with Rett Syndrome
7:31am
a director’s, officer’s or employee’s responsibilities. Among other things, the Code of Conduct:
clarifies the Company’s (i) anti-corruption standards
S-4/A
ma9kowuek9r561a6g
28 Sep 23
Registration of securities issued in business combination transactions (amended)
4:28pm
S-4
xh9l9zayl6gmftkr6nv
18 Aug 23
Registration of securities issued in business combination transactions
6:19pm
8-K
EX-1.1
ekh9mzh6sc7w
4 Nov 21
Entry into a Material Definitive Agreement
4:58pm
8-K
EX-1.1
2q8l rsoeg87d9dgqld8
2 Jul 20
Announces Pricing of $76.2 Million Public Offering
4:09pm